Press "esc" to clear
Go to Advanced Search

Showing results

110 of 757
DrAndrewElliott.jpg

Article ID: 703942

Synthetic Cartilage Gives Husband and Wife a Foothold on Painful Toe Arthritis

Hospital for Special Surgery

A husband and wife suffering from severe toe arthritis are now pain-free and back to their active lifestyle after surgery with a synthetic cartilage implant at Hospital for Special Surgery.

Released:
13-Nov-2018 4:05 PM EST
Healthy_Human_T_Cell.jpg
  • Embargo expired:
    12-Nov-2018 11:00 AM EST

Article ID: 703550

Suicide Handshakes Kill Precursor T Cells that Pose Autoimmune Dangers

Georgia Institute of Technology

The mechanisms that trigger the elimination of T cells that pose autoimmune dangers work very mechanically via physical forces. Nascent T cells must loosen their grip on human antigens within a reasonable time, in order to advance and defend the body. But if the nascent T cells, thymocytes, grip the human antigens too tightly, the immune cells must die. Here's how the grip of death works.

Released:
7-Nov-2018 1:05 PM EST
Randolph.jpg

Article ID: 703623

Link Between Autoimmune, Heart Disease Explained in Mice

Washington University in St. Louis

Autoimmune diseases such as psoriasis more than double the risk of cardiovascular disease. A new study shows that immune cells that arise during autoimmune disease can cause cholesterol to become trapped inside blood vessels.

Released:
8-Nov-2018 11:00 AM EST
  • Embargo expired:
    7-Nov-2018 1:00 PM EST

Article ID: 703432

Building block of "happiness hormone" is key to controlling immunity in cancer and auto-immune diseases.

IMP - Research Institute of Molecular Pathology

Scientists at IMBA - Institute of Molecular Biotechnology at the Austrian Academy of Sciences - together with the Boston Children's Hospital at Harvard, demonstrate a completely new way of combating autoimmune diseases and cancer.

Released:
6-Nov-2018 1:00 PM EST

Article ID: 703237

Progentec Diagnostics, Inc. Raises Funds to Support Advances in Lupus Detection and Management

Progentec Diagnostics, Inc.

Progentec Diagnostics, Inc. ("Progentec"), a leader in the development of technological innovations in the field of diagnostics, today announced the completion of a second round of funding co-led by i2E and Chicago-based OCA Ventures.

Released:
1-Nov-2018 2:05 PM EDT

Article ID: 703141

Cytokine levels could predict immunotherapy problems

UT Southwestern Medical Center

Researchers at UT Southwestern have identified blood-based biomarkers that may help identify those patients at greatest risk of developing autoimmune side effects from the treatment.

Released:
31-Oct-2018 11:05 AM EDT
STIMstructure.png
  • Embargo expired:
    31-Oct-2018 5:00 AM EDT

Article ID: 702886

LJI investigators discover how protein pair controls cellular calcium signals

La Jolla Institute for Immunology

Two studies recently published by La Jolla Institute for Immunology (LJI) investigators Patrick Hogan, PhD, and Aparna Gudlur, PhD, report how a calcium-sensing protein called STIM1 signals that it's time to initiate calcium retrieval and then relays that message to its partner, the calcium channel ORAI.

Released:
26-Oct-2018 1:35 PM EDT

Article ID: 702997

Radiation therapy cuts low risk of recurrence by nearly three-fourths for patients with “good risk” breast cancer

American Society for Radiation Oncology (ASTRO)

A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but can lower that risk even further with radiation therapy, finds a new long-term clinical trial report. These 12-year follow-up data from the only prospective, randomized trial to compare recurrence outcomes after treatment for low-risk ductal carcinoma in situ (DCIS) were presented last week at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Released:
29-Oct-2018 4:45 PM EDT

Article ID: 702998

Aggressive treatment for some stage IV lung cancer patients can dramatically improve overall survival

American Society for Radiation Oncology (ASTRO)

Adding radiation therapy or surgery to systemic therapy for stage IV lung cancer patients whose cancer has spread to a limited number of sites can extend overall survival time significantly, according to new results from a multicenter, randomized, controlled phase II study. The findings were presented last week at the 60th Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Released:
29-Oct-2018 4:40 PM EDT

Showing results

110 of 757

Chat now!